Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Clínica Las Condes Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda Clínica Las Condes için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare kazanç büyümesi	28.0%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Jul 02

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Apr 30

Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price

Mar 28

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Jan 12

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Oct 24

Returns At Clínica Las Condes (SNSE:LAS CONDES) Are On The Way Up

Sep 27

Clínica Las Condes (SNSE:LAS CONDES) Is Experiencing Growth In Returns On Capital

Jun 21

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

May 19

Clínica Las Condes (SNSE:LAS CONDES) Is Doing The Right Things To Multiply Its Share Price

Aug 25

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Apr 20

Is Clínica Las Condes (SNSE:LAS CONDES) Using Too Much Debt?

Mar 10

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Oct 07

A Look At The Fair Value Of Clínica Las Condes S.A. (SNSE:LAS CONDES)

Aug 28

Does Clínica Las Condes (SNSE:LAS CONDES) Have A Healthy Balance Sheet?

May 31

Some Investors May Be Worried About Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Apr 16

A Look At Clínica Las Condes' (SNSE:LAS CONDES) Share Price Returns

Mar 12

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

Feb 05

Should You Be Impressed By Clínica Las Condes' (SNSE:LAS CONDES) Returns on Capital?

Jan 01

Clínica Las Condes'(SNSE:LAS CONDES) Share Price Is Down 36% Over The Past Five Years.

Nov 27

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Clínica Las Condes yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

SNSE:LAS CONDES - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CLP Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	196,410	-2,977	2,729	5,996	N/A
3/31/2024	198,852	-2,146	8,110	12,433	N/A
12/31/2023	202,263	-3,401	7,991	13,589	N/A
9/30/2023	211,636	-3,614	10,542	18,272	N/A
6/30/2023	225,539	-1,240	26,211	35,639	N/A
3/31/2023	245,360	647	37,113	47,320	N/A
12/31/2022	259,992	4,047	37,205	49,213	N/A
9/30/2022	271,371	939	47,308	58,684	N/A
6/30/2022	279,943	8,916	36,052	46,376	N/A
3/31/2022	282,389	13,362	39,361	49,566	N/A
12/31/2021	276,854	18,417	29,900	37,601	N/A
9/30/2021	269,279	28,622	25,322	30,999	N/A
6/30/2021	248,857	19,437	18,136	22,066	N/A
3/31/2021	220,659	4,933	644	3,216	N/A
12/31/2020	212,266	-5,280	11,622	15,822	N/A
9/30/2020	202,808	-12,095	10,114	15,277	N/A
6/30/2020	209,306	-7,451	18,590	24,333	N/A
3/31/2020	224,860	1,750	22,405	29,031	N/A
12/31/2019	226,194	5,219	15,660	20,066	N/A
9/30/2019	227,965	8,375	25,815	29,195	N/A
6/30/2019	226,087	7,081	27,989	30,625	N/A
3/31/2019	224,119	4,778	13,992	16,806	N/A
12/31/2018	219,400	4,505	10,237	16,241	N/A
9/30/2018	206,418	-4,676	7,367	16,168	N/A
6/30/2018	203,297	-5,581	-4,785	8,939	N/A
3/31/2018	198,778	-5,100	N/A	24,030	N/A
12/31/2017	194,920	-10,346	N/A	25,341	N/A
9/30/2017	195,766	-9,252	N/A	21,246	N/A
6/30/2017	199,616	-5,559	N/A	8,245	N/A
3/31/2017	197,397	-3,258	N/A	3,253	N/A
12/31/2016	196,473	1,500	N/A	-7,191	N/A
9/30/2016	195,806	5,303	N/A	-20,704	N/A
6/30/2016	188,904	5,370	N/A	-4,569	N/A
3/31/2016	183,305	4,374	N/A	-5,973	N/A
12/31/2015	178,054	5,270	N/A	428	N/A
9/30/2015	174,007	7,929	N/A	9,025	N/A
6/30/2015	165,973	9,217	N/A	14,562	N/A
3/31/2015	160,604	12,272	N/A	15,747	N/A
12/31/2014	156,386	14,227	N/A	22,725	N/A
9/30/2014	151,772	17,275	N/A	24,894	N/A
6/30/2014	146,840	17,629	N/A	21,381	N/A
3/31/2014	142,837	18,135	N/A	23,327	N/A
12/31/2013	138,851	18,104	N/A	20,125	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: LAS CONDES 'un tahmini kazanç büyümesinin tasarruf oranının ( 5.5% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: LAS CONDES 'un kazançlarının CL pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: LAS CONDES şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: LAS CONDES şirketinin gelirinin CL pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: LAS CONDES şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: LAS CONDES 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Clínica Las Condes Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

New major risk - Financial position

Second quarter 2024 earnings released: CL$5.00 loss per share (vs CL$94.00 profit in 2Q 2023)

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Less than half of directors are independent

First quarter 2024 earnings released: EPS: CL$61.00 (vs CL$88.57 loss in 1Q 2023)

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Full year 2023 earnings released: CL$406 loss per share (vs CL$483 profit in FY 2022)

Clínica Las Condes S.A.'s (SNSE:LAS CONDES) Business Is Yet to Catch Up With Its Share Price

Now 22% overvalued after recent price rise

Now 22% overvalued after recent price rise

New major risk - Share price stability

Returns On Capital At Clínica Las Condes (SNSE:LAS CONDES) Paint A Concerning Picture

Third quarter 2023 earnings released: CL$419 loss per share (vs CL$136 loss in 3Q 2022)

Is Clínica Las Condes (SNSE:LAS CONDES) A Risky Investment?

Returns At Clínica Las Condes (SNSE:LAS CONDES) Are On The Way Up

New major risk - Financial position

Second quarter 2023 earnings released: EPS: CL$94.00 (vs CL$319 in 2Q 2022)

New major risk - Financial position

Clínica Las Condes (SNSE:LAS CONDES) Is Experiencing Growth In Returns On Capital

Investor sentiment improves as stock rises 17%

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

Investor sentiment improves as stock rises 16%

Upcoming dividend of CL$145 per share at 1.3% yield

Investor sentiment improves as stock rises 21%

Full year 2022 earnings released: EPS: CL$483 (vs CL$2,199 in FY 2021)

Third quarter 2022 earnings released: CL$136 loss per share (vs CL$816 profit in 3Q 2021)

No independent directors

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CL$319 (vs CL$850 in 2Q 2021)

Clínica Las Condes (SNSE:LAS CONDES) Is Doing The Right Things To Multiply Its Share Price

First quarter 2022 earnings released: EPS: CL$317 (vs CL$921 in 1Q 2021)

Upcoming dividend of CL$660 per share

No independent directors

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Full year 2021 earnings released: EPS: CL$2,199 (vs CL$630 loss in FY 2020)

Is Clínica Las Condes (SNSE:LAS CONDES) Using Too Much Debt?

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

There's Been No Shortage Of Growth Recently For Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

Investor sentiment improved over the past week

A Look At The Fair Value Of Clínica Las Condes S.A. (SNSE:LAS CONDES)

Second quarter 2021 earnings released: EPS CL$850 (vs CL$882 loss in 2Q 2020)

Does Clínica Las Condes (SNSE:LAS CONDES) Have A Healthy Balance Sheet?

First quarter 2021 earnings released: EPS CL$921 (vs CL$298 loss in 1Q 2020)

Some Investors May Be Worried About Clínica Las Condes' (SNSE:LAS CONDES) Returns On Capital

A Look At Clínica Las Condes' (SNSE:LAS CONDES) Share Price Returns

Full year 2020 earnings released: CL$630 loss per share (vs CL$623 profit in FY 2019)

New 90-day low: CL$22,499

Clínica Las Condes (SNSE:LAS CONDES) Takes On Some Risk With Its Use Of Debt

New 90-day low: CL$23,820

Should You Be Impressed By Clínica Las Condes' (SNSE:LAS CONDES) Returns on Capital?

Third quarter 2020 earnings released: CL$281 loss per share

Clínica Las Condes'(SNSE:LAS CONDES) Share Price Is Down 36% Over The Past Five Years.

New 90-day low: CL$26,721

First half earnings released

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin